CP and myeloid sarcoma: To get a comprehensive overview of CP alterations in progressive MS and reveal potential disruptions in any of its critical attributes, including secretion, barrier formation or the immunological milieu, we performed RNA sequencing (RNA-seq) of human postmortem CP samples from the lateral ventricle of progressive MS patients and non-neurological controls.